These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 31010819)
1. Breast Cancer Subtype Classification Using 4-Plex Droplet Digital PCR. Chen W; Zheng J; Wu C; Liu S; Chen Y; Liu X; Du J; Wang J Clin Chem; 2019 Aug; 65(8):1051-1059. PubMed ID: 31010819 [TBL] [Abstract][Full Text] [Related]
2. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414 [TBL] [Abstract][Full Text] [Related]
3. Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform. Wu NC; Wong W; Ho KE; Chu VC; Rizo A; Davenport S; Kelly D; Makar R; Jassem J; Duchnowska R; Biernat W; Radecka B; Fujita T; Klein JL; Stonecypher M; Ohta S; Juhl H; Weidler JM; Bates M; Press MF Breast Cancer Res Treat; 2018 Nov; 172(2):327-338. PubMed ID: 30120700 [TBL] [Abstract][Full Text] [Related]
4. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer. Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315 [TBL] [Abstract][Full Text] [Related]
5. ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6. Filipits M; Rudas M; Singer CF; Fitzal F; Bago-Horvath Z; Greil R; Balic M; Lax SF; Halper S; Hulla W; Wu NC; Liu X; Weidler J; Bates M; Hlauschek D; Gnant M; Dubsky P ESMO Open; 2021 Aug; 6(4):100228. PubMed ID: 34371382 [TBL] [Abstract][Full Text] [Related]
6. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples. Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802 [TBL] [Abstract][Full Text] [Related]
7. Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer. Gupta S; Mani NR; Carvajal-Hausdorf DE; Bossuyt V; Ho K; Weidler J; Wong W; Rhees B; Bates M; Rimm DL Lab Invest; 2018 Aug; 98(8):1076-1083. PubMed ID: 29858579 [TBL] [Abstract][Full Text] [Related]
8. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer. Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205 [TBL] [Abstract][Full Text] [Related]
9. The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis. Du X; Li XQ; Li L; Xu YY; Feng YM Breast Cancer Res Treat; 2013 Feb; 138(1):59-67. PubMed ID: 23397283 [TBL] [Abstract][Full Text] [Related]
10. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue. Belgrader P; Tanner SC; Regan JF; Koehler R; Hindson BJ; Brown AS Clin Chem; 2013 Jun; 59(6):991-4. PubMed ID: 23358413 [TBL] [Abstract][Full Text] [Related]
11. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882 [TBL] [Abstract][Full Text] [Related]
12. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®. Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348 [TBL] [Abstract][Full Text] [Related]
13. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples. Wang X; Wu Y; Song X; Sun C; Wu C; Feng H J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323 [TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer. Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033 [TBL] [Abstract][Full Text] [Related]
15. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry. Wirtz RM; Sihto H; Isola J; Heikkilä P; Kellokumpu-Lehtinen PL; Auvinen P; Turpeenniemi-Hujanen T; Jyrkkiö S; Lakis S; Schlombs K; Laible M; Weber S; Eidt S; Sahin U; Joensuu H Breast Cancer Res Treat; 2016 Jun; 157(3):437-46. PubMed ID: 27220750 [TBL] [Abstract][Full Text] [Related]
16. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue. Hartmann K; Schlombs K; Laible M; Gürtler C; Schmidt M; Sahin U; Lehr HA Diagn Pathol; 2018 Oct; 13(1):83. PubMed ID: 30342538 [TBL] [Abstract][Full Text] [Related]
17. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection. Tramm T; Hennig G; Kyndi M; Alsner J; Sørensen FB; Myhre S; Sørlie T; Overgaard J Virchows Arch; 2013 Dec; 463(6):775-86. PubMed ID: 24100522 [TBL] [Abstract][Full Text] [Related]
18. Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples. Wilson TR; Xiao Y; Spoerke JM; Fridlyand J; Koeppen H; Fuentes E; Huw LY; Abbas I; Gower A; Schleifman EB; Desai R; Fu L; Sumiyoshi T; O'Shaughnessy JA; Hampton GM; Lackner MR Breast Cancer Res Treat; 2014 Nov; 148(2):315-25. PubMed ID: 25338319 [TBL] [Abstract][Full Text] [Related]
19. ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors. Hertz DL; Henry NL; Kidwell KM; Thomas D; Goddard A; Azzouz F; Speth K; Li L; Banerjee M; Thibert JN; Kleer CG; Stearns V; Hayes DF; Skaar TC; Rae JM Physiol Genomics; 2016 Sep; 48(9):688-98. PubMed ID: 27542969 [TBL] [Abstract][Full Text] [Related]
20. Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples. Heredia NJ; Belgrader P; Wang S; Koehler R; Regan J; Cosman AM; Saxonov S; Hindson B; Tanner SC; Brown AS; Karlin-Neumann G Methods; 2013 Jan; 59(1):S20-3. PubMed ID: 23036330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]